Back to Journals » Patient Preference and Adherence » Volume 8

Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing–remitting multiple sclerosis treatment

Total article views   HTML views PDF downloads Totals
20,840 Dovepress* 15,250+ 1,985 17,235
PubMed Central* 5,590 1,024 6,614
Totals 20,840 3,009 23,849
*Since 21 August 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar